跳至主要内容
临床试验/NCT06681805
NCT06681805已完成不适用

Role of Prophylactic Mirtazapine and Different Doses of Intrathecal Morphine in Preventing Nausea and Vomiting After Cesarean Section: A Randomized Controlled Trial

Kafrelsheikh University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Incidence of postoperative nausea and vomiting

研究概览

简要总结

The aim of this work was to evaluate the role of prophylactic mirtazapine and different doses of intrathecal morphine in preventing nausea and vomiting.

详细描述

It is common practice to provide intrathecal morphine to alleviate postoperative pain because of its powerful and long-lasting analgesic effects. Mirtazapine is a noradrenergic and specific serotonergic antidepressant. It is anxiolytic by its antagonist of the 5HT2 receptor and is strongly sleep-inducing. Its antagonist at 5-hydroxytryptamine subtype 3 (5-HT3) receptor may help to prevent nausea and vomiting

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 18-40 years.
  • American Society of Anesthesiologists (ASA) physical status I-II.
  • Scheduled for caesarean section under spinal anesthesia

排除标准

  • Known hypersensitivity to mirtazapine.
  • Gastrointestinal illness.
  • Diabetes mellitus.
  • Use of opioids or any medication with known antiemetic properties within 48 hours before surgery.
  • Mental disorders.
  • Spinal anesthesia contraindications.
  • Taking antidepressants or antipsychotic medications.

研究组 & 干预措施

Groups I

Experimental

Patients received 30mg of oral mirtazapine one hour before surgery plus 10 mg of bupivacaine 0.5% along with 0.2 mg of morphine.

干预措施: Mirtazapine + Bupivacaine + Morphine (Drug)

Groups II

Experimental

Patients received 30mg of oral mirtazapine one hour before surgery plus 10 mg of bupivacaine 0.5%, along with 0.1 mg of morphine.

干预措施: Mirtazapine + Bupivacaine + Morphine (Drug)

Groups III

Placebo Comparator

Patients received a placebo one hour before surgery plus 10 mg of bupivacaine 0.5%, along with 0.2 mg of morphine.

干预措施: Placebo + Bupivacaine + Morphine (Drug)

Groups IV

Placebo Comparator

Patients received a placebo one hour before surgery plus 10 mg of bupivacaine 0.5%, along with 0.1 mg of morphine.

干预措施: Placebo+ Bupivacaine + Morphine (Drug)

结局指标

主要结局

Incidence of postoperative nausea and vomiting

时间窗: 24 hours postoperatively

Incidence of postoperative nausea and vomiting was recorded at 3, 6, 12, 18, 24 hours postoperatively.

次要结局

  • Degree of pain(24 hours postoperatively)
  • Time to first rescue analgesia(24 hours postoperatively)
  • Total pethidine consumption(24 hours postoperatively)
  • Incidence of adverse events(24 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Basma Mohamed Ghoniem

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Kafrelshiekh University, Kafrelshiekh, Egypt

Kafrelsheikh University

研究点 (1)

Loading locations...

相似试验